Log in to your Inderes Free account to see all free content on this page.
Intervacc
0.74 SEK
+0.27 %
Less than 1K followers
IVACC
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Intervacc
EV/S
Median 2019-2021
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 13.45 | 39.34 | 39.64 | 19.37 | 5.43 | 1.00 | 0.92 |
| Shares | 52.6 | 67.3 | 67.3 | 67.8 | 88.3 | 88.3 | 340.8 |
| Market cap | 708.1 | 2,646.5 | 2,668.5 | 1,312.8 | 479.4 | 88.6 | 314.9 |
| Enterprise value | 655.5 | 2,482.3 | 2,552.8 | - | - | - | - |
| EV/S | 54.0 | 519.3 | 487.1 | - | - | - | - |
| EV/EBITDA | neg. | neg. | neg. | - | - | - | - |
| EV/EBIT | neg. | neg. | neg. | - | - | - | - |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | 3.22 | 7.84 | 8.66 | 5.25 | 2.01 | 0.55 | 1.15 |
| P/S | 58.3 | 553.7 | 509.2 | 135.6 | 59.8 | 7.5 | 15.7 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 92.7 % | 95.0 % | 93.6 % | 94.4 % | 91.6 % | 86.7 % | 93.4 % |
| Gearing ratio | - | - | - | - | - | - | - |
Login required
This content is only available for logged in users